Swedish Orphan Biovitrum AB (publ)
STO:SOBI

Watchlist Manager
Swedish Orphan Biovitrum AB (publ) Logo
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Watchlist
Price: 277.2 SEK -0.36% Market Closed
Market Cap: 98.7B SEK

Intrinsic Value

The intrinsic value of one SOBI stock under the Base Case scenario is 399.8 SEK. Compared to the current market price of 277.2 SEK, Swedish Orphan Biovitrum AB (publ) is Undervalued by 31%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SOBI Intrinsic Value
399.8 SEK
Undervaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Swedish Orphan Biovitrum AB (publ)

Valuation History Unavailable

Historical valuation for SOBI cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare SOBI to

Fundamental Analysis

Swedish Orphan Biovitrum AB (publ)
STO:SOBI
SE
Biotechnology
Market Cap
95.2B SEK
IPO
Sep 15, 2006
SE
Biotechnology
Market Cap
95.2B SEK
IPO
Sep 15, 2006
Price
krfalse
EPS
krfalse
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SOBI?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Swedish Orphan Biovitrum AB (publ)
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Swedish Orphan Biovitrum AB (publ)

Current Assets 11.7B
Cash & Short-Term Investments 997m
Receivables 6.8B
Other Current Assets 3.9B
Non-Current Assets 58.4B
Long-Term Investments 176m
PP&E 1.6B
Intangibles 55.4B
Other Non-Current Assets 1.3B
Efficiency

Free Cash Flow Analysis
Swedish Orphan Biovitrum AB (publ)

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Swedish Orphan Biovitrum AB (publ)

Revenue
26.2B SEK
Cost of Revenue
-5.7B SEK
Gross Profit
20.5B SEK
Operating Expenses
-14.7B SEK
Operating Income
5.8B SEK
Other Expenses
-1.8B SEK
Net Income
4B SEK
Fundamental Scores

SOBI Profitability Score
Profitability Due Diligence

Swedish Orphan Biovitrum AB (publ)'s profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Operating Income
59/100
Profitability
Score

Swedish Orphan Biovitrum AB (publ)'s profitability score is 59/100. The higher the profitability score, the more profitable the company is.

SOBI Solvency Score
Solvency Due Diligence

Swedish Orphan Biovitrum AB (publ)'s solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
49/100
Solvency
Score

Swedish Orphan Biovitrum AB (publ)'s solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SOBI Price Targets Summary
Swedish Orphan Biovitrum AB (publ)

Wall Street analysts forecast SOBI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SOBI is 352.49 SEK with a low forecast of 287.85 SEK and a high forecast of 402.15 SEK.

Lowest
Price Target
287.85 SEK
4% Upside
Average
Price Target
352.49 SEK
27% Upside
Highest
Price Target
402.15 SEK
45% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Swedish Orphan Biovitrum AB (publ)
does not pay dividends
Shareholder Yield

Current shareholder yield for SOBI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

SOBI Insider Trading
Buy and sell transactions by insiders

SOBI News

What is the Intrinsic Value of one SOBI stock?

The intrinsic value of one SOBI stock under the Base Case scenario is 399.8 SEK.

Is SOBI stock undervalued or overvalued?

Compared to the current market price of 277.2 SEK, Swedish Orphan Biovitrum AB (publ) is Undervalued by 31%.

Back to Top